AngioDynamics, Inc.: stock overview

ANGONASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$11.87

November 13, 2026Market cap $499M

DCF calculator

What Ploutos Investor adds for AngioDynamics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

AngioDynamics had revenue of $325M over the last 12 months and a net loss of $33M. Revenue grew by 1.9% a year on average over the last 5 years. It holds more cash than debt, by $32M. It pays no dividend.

From its SEC filings (latest fiscal year to May 31, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$499M
42.05M shares
P/E
–
Revenue, 12 months
$325M
+1.9% a year over 5 years
Net margin
-10.1%
FY2025: -11.5%, above 31% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+2.6% a year over 2 years

  • FY2026May 31, 202610-K
    Revenue$320M
  • FY2025May 31, 202510-K
    Revenue$292M
  • FY2024May 31, 202410-K
    Revenue$304M

Fiscal years in figures

ANGO's revenue, profit, cash flow and dividend with each year-end price, from FY2010 to FY2023, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $414M
$499M
Enterprise value 
$467M
P/E 
–
EV / EBIT 
–
EV / Revenue 
1.4
P/B 3-year median: 2.3
3.0
FCF yield 3-year median: -3.5%
0.3%
Earnings yield 3-year median: -8.1%
–

Profitability

Gross margin 
55.7%
Operating margin 
-11.2%
Net margin 3-year median: -11.6%
-10.1%
ROIC 
-16.7%
ROIC, 5-year average 
-24.8%
ROE 
-19.1%

Growth

Revenue, yearly change 
+9.5%
EPS, yearly change 
–
FCF, yearly change 
–
Revenue, average a year 
+1.9%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$34M
Total debt 
$7.3M
Of which operating leases 
$5.0M
Net cash 
$32M
Net debt / EBITDA 
–
Interest cover 
–
Current ratio 
2.40

Balance sheet of August 31, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+3.5%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

54.6%

Above 45% of the 161 companies in its industry, and 73% of all.

Operating margin

-12.5%

Above 29% of the 186 companies in its industry, and 18% of all.

Net margin

-11.5%

Above 31% of the 189 companies in its industry, and 17% of all.

ROE

-20.8%

Above 26% of the 174 companies in its industry, and 14% of all.

ROA

-13.6%

Above 27% of the 190 companies in its industry, and 12% of all.

Revenue growth

9.5%

Above 57% of the 186 companies in its industry, and 60% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
ANGIODYNAMICS INC
CIK
1275187
Exchange
NASDAQ
Industry (SIC)
3841 · Surgical & Medical Instruments & Apparatus
Fiscal year ends
May 31
Latest annual report
May 31, 2026
Reporting currency
USD
Shares
42.05M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do AngioDynamics's filings show?

These are AngioDynamics's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ANGO

Didn't find what you were looking for?

Ask us
What is ANGO's market cap?

AngioDynamics, Inc.'s market cap is $499M, at a price of $11.87 on November 13, 2026 and 42.05M shares.

How much revenue does ANGO have?

AngioDynamics had revenue of $325M over the last 12 months. Over the last 5 years it changed by +1.9% a year on average.

Does ANGO pay a dividend?

No. AngioDynamics paid no regular dividend over the last 12 months.

Where do the figures come from?

From AngioDynamics, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.